Personalized treatment for urogenital cancers based on microbiome analysis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the impact of microbiome on the treatment of urogenital cancers by comparing two groups of patients undergoing surgical treatment. One group will receive antibiotics while the other will receive a placebo, allowing researchers to assess the role of microbiome in recovery and treatment outcomes. The study aims to determine if personalized treatment based on microbiome can improve patient outcomes in localized urological cancers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Biopsy verified diagnosis of urological cancer, localized disease

Exclusion Criteria:

* Hospitalization within three months of surgery
* Antibiotics within three months of surgery
* Infectious disease, including UTI's within three months of surgery
* History of cancers of the genitourinary tract
* Diabetes

Where it's running

• Zealand University Hospital
  Roskilde, Denmark Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Single-use gastroscopes vs reusable in elective and subacute gastroscopy

  This study tests whether single-use gastroscopes work as well as reusable ones for adults having gastroscopy when endoscope reprocessing capacity is limited.

  Recruiting Zealand University Hospital · Køge · NCT07727226

• How dexamethasone affects blood sugar during and after non-cardiac surgery

  We will see if a standard dose of dexamethasone raises blood sugar in adults having elective non-cardiac surgery and whether continuous glucose monitors detect changes better than finger-prick tests.

  Recruiting Zealand University Hospital · Roskilde · NCT07573930

• Calcium electroporation for bladder tumors in adults who can’t have standard treatments

  This first‑in‑human study tests intravesical calcium electroporation to see if it is safe and whether it shows early signs of benefit in adults with bladder tumors who have few other options.

  Recruiting Phase 1 Zealand University Hospital · Roskilde · NCT07555769

• Connecting hospitalized patients to alcohol care

  This pilot tests whether inviting in-hospital patients with alcohol use issues to meet an alcohol-use therapist for up to 10 sessions, versus giving guidance to seek care in the community, is feasible.

  Recruiting Zealand University Hospital · Køge · NCT07482150

• Singing training versus usual care after lung cancer surgery (6–18 months post-operation)

  This trial will test whether an online singing program can help people who had surgery for early-stage non-small cell lung cancer 6–18 months ago feel better, breathe easier, and improve physical fitness.

  Recruiting at 5 sites Zealand University Hospital · Copenhagen and 4 other locations · NCT07460999

• Contrast-enhanced ultrasound to target liver metastases from colorectal cancer

  This trial will try low- and high-intensity contrast-enhanced ultrasound in adults whose colorectal cancer has spread to the liver to see if it safely makes tumors more immune-active.

  Recruiting at 2 sites Zealand University Hospital · Copenhagen and 1 other locations · NCT07365527

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.